The	the	O	O	O	O
activation	activation	O	O	O	O
of	of	O	O	O	O
spinal	spinal	O	O	O	O
N-methyl-D-aspartate	n-methyl-d-aspartate	O	O	O	O
receptors	receptors	O	O	O	O
may	may	O	O	O	O
contribute	contribute	O	O	O	O
to	to	O	O	O	O
degeneration	degeneration	O	O	O	O
of	of	O	O	O	O
spinal	spinal	O	O	O	O
motor	motor	O	O	O	O
neurons	neurons	O	O	O	O
induced	induced	O	O	O	O
by	by	O	O	O	O
neuraxial	neuraxial	O	O	O	O
morphine	morphine	CHEMICALS	O	OTHERS	I
after	after	O	O	O	O
a	a	O	O	O	O
noninjurious	noninjurious	O	O	O	O
interval	interval	O	O	O	O
of	of	O	O	O	O
spinal	spinal	O	DISEASE	OTHERS	I
cord	cord	O	DISEASE	OTHERS	I
ischemia	ischemia	O	DISEASE	OTHERS	I
.	.	O	O	O	O

We	we	O	O	O	O
investigated	investigated	O	O	O	O
the	the	O	O	O	O
relationship	relationship	O	O	O	O
between	between	O	O	O	O
the	the	O	O	O	O
degeneration	degeneration	O	O	O	O
of	of	O	O	O	O
spinal	spinal	O	O	O	O
motor	motor	O	O	O	O
neurons	neurons	O	O	O	O
and	and	O	O	O	O
activation	activation	O	O	O	O
of	of	O	O	O	O
N-methyl-d-aspartate	n-methyl-d-aspartate	O	O	O	O
(	(	O	O	O	O
NMDA	nmda	CHEMICALS	O	OTHERS	I
)	)	O	O	O	O
receptors	receptors	O	O	O	O
after	after	O	O	O	O
neuraxial	neuraxial	O	O	O	O
morphine	morphine	CHEMICALS	O	OTHERS	I
following	following	O	O	O	O
a	a	O	O	O	O
noninjurious	noninjurious	O	O	O	O
interval	interval	O	O	O	O
of	of	O	O	O	O
aortic	aortic	O	O	OTHERS	I
occlusion	occlusion	O	O	OTHERS	I
in	in	O	O	O	O
rats	rats	O	O	O	O
.	.	O	O	O	O

Spinal	spinal	O	DISEASE	OTHERS	I
cord	cord	O	DISEASE	OTHERS	I
ischemia	ischemia	O	DISEASE	OTHERS	I
was	was	O	O	O	O
induced	induced	O	O	O	O
by	by	O	O	O	O
aortic	aortic	O	O	OTHERS	I
occlusion	occlusion	O	O	OTHERS	I
for	for	O	O	O	O
6	6	O	O	O	O
min	min	O	O	O	O
with	with	O	O	O	O
a	a	O	O	O	O
balloon	balloon	O	O	O	O
catheter	catheter	O	O	O	O
.	.	O	O	O	O

In	in	O	O	O	O
a	a	O	O	O	O
microdialysis	microdialysis	O	O	O	O
study	study	O	O	O	O
,	,	O	O	O	O
10	10	O	O	O	O
muL	mul	O	O	O	O
of	of	O	O	O	O
saline	saline	O	O	O	O
(	(	O	O	O	O
group	group	O	O	O	O
C	c	O	O	OTHERS	I
;	;	O	O	O	O
n	n	O	O	OTHERS	I
=	=	O	O	O	O
8)	8)	O	O	O	O
or	or	O	O	O	O
30	30	O	O	O	O
mug	mug	O	O	O	O
of	of	O	O	O	O
morphine	morphine	CHEMICALS	O	OTHERS	I
(	(	O	O	O	O
group	group	O	O	O	O
M	m	O	O	O	O
;	;	O	O	O	O
n	n	O	O	OTHERS	I
=	=	O	O	O	O
8)	8)	O	O	O	O
was	was	O	O	O	O
injected	injected	O	O	O	O
intrathecally	intrathecally	O	O	O	O
(	(	O	O	O	O
IT	it	O	O	O	O
)	)	O	O	O	O
0.5	0.5	O	O	O	O
h	h	CHEMICALS	O	OTHERS	I
after	after	O	O	O	O
reflow	reflow	O	O	O	O
,	,	O	O	O	O
and	and	O	O	O	O
30	30	O	O	O	O
mug	mug	O	O	O	O
of	of	O	O	O	O
morphine	morphine	CHEMICALS	O	OTHERS	I
(	(	O	O	O	O
group	group	O	O	O	O
SM	sm	O	O	O	O
;	;	O	O	O	O
n	n	O	O	OTHERS	I
=	=	O	O	O	O
8)	8)	O	O	O	O
or	or	O	O	O	O
10	10	O	O	O	O
muL	mul	O	O	O	O
of	of	O	O	O	O
saline	saline	O	O	O	O
(	(	O	O	O	O
group	group	O	O	O	O
SC	sc	O	O	O	O
;	;	O	O	O	O
n	n	O	O	OTHERS	I
=	=	O	O	O	O
8)	8)	O	O	O	O
was	was	O	O	O	O
injected	injected	O	O	O	O
IT	it	O	O	O	O
0.5	0.5	O	O	O	O
h	h	CHEMICALS	O	OTHERS	I
after	after	O	O	O	O
sham	sham	O	O	O	O
operation	operation	O	O	O	O
.	.	O	O	O	O

Microdialysis	microdialysis	O	O	O	O
samples	samples	O	O	O	O
were	were	O	O	O	O
collected	collected	O	O	O	O
preischemia	preischemia	O	O	O	O
,	,	O	O	O	O
before	before	O	O	O	O
IT	it	O	O	O	O
injection	injection	O	O	O	O
,	,	O	O	O	O
and	and	O	O	O	O
at	at	O	O	O	O
2	2	O	O	O	O
,	,	O	O	O	O
4	4	O	O	O	O
,	,	O	O	O	O
8	8	O	O	O	O
,	,	O	O	O	O
24	24	O	O	O	O
,	,	O	O	O	O
and	and	O	O	O	O
48	48	O	O	O	O
h	h	CHEMICALS	O	OTHERS	I
of	of	O	O	O	O
reperfusion	reperfusion	O	O	O	O
(	(	O	O	O	O
after	after	O	O	O	O
IT	it	O	O	O	O
injection	injection	O	O	O	O
)	)	O	O	O	O
.	.	O	O	O	O

Second	second	O	O	O	O
,	,	O	O	O	O
we	we	O	O	O	O
investigated	investigated	O	O	O	O
the	the	O	O	O	O
effect	effect	O	O	O	O
of	of	O	O	O	O
IT	it	O	O	O	O
MK-801	mk-801	CHEMICALS	O	OTHERS	I
(	(	O	O	O	O
30	30	O	O	O	O
mug	mug	O	O	O	O
)	)	O	O	O	O
on	on	O	O	O	O
the	the	O	O	O	O
histopathologic	histopathologic	O	O	O	O
changes	changes	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
spinal	spinal	O	O	O	O
cord	cord	O	O	O	O
after	after	O	O	O	O
morphine-induced	morphine-induced	O	O	O	O
spastic	spastic	O	O	OTHERS	I
paraparesis	paraparesis	O	O	OTHERS	I
.	.	O	O	O	O

After	after	O	O	O	O
IT	it	O	O	O	O
morphine	morphine	CHEMICALS	O	OTHERS	I
,	,	O	O	O	O
the	the	O	O	O	O
cerebrospinal	cerebrospinal	O	O	O	O
fluid	fluid	O	O	O	O
(	(	O	O	O	O
CSF	csf	O	O	O	O
)	)	O	O	O	O
glutamate	glutamate	CHEMICALS	O	OTHERS	I
concentration	concentration	O	O	O	O
was	was	O	O	O	O
increased	increased	O	O	O	O
in	in	O	O	O	O
group	group	O	O	O	O
M	m	O	O	O	O
relative	relative	O	O	O	O
to	to	O	O	O	O
both	both	O	O	O	O
baseline	baseline	O	O	O	O
and	and	O	O	O	O
group	group	O	O	O	O
C	c	O	O	OTHERS	I
(	(	O	O	O	O
P	p	O	O	OTHERS	I
<	<	O	O	O	O
0.05	0.05	O	O	O	O
)	)	O	O	O	O
.	.	O	O	O	O

This	this	O	O	O	O
increase	increase	O	O	O	O
persisted	persisted	O	O	O	O
for	for	O	O	O	O
8	8	O	O	O	O
hrs	hrs	O	O	O	O
.	.	O	O	O	O

IT	it	O	O	O	O
MK-801	mk-801	CHEMICALS	O	OTHERS	I
significantly	significantly	O	O	O	O
reduced	reduced	O	O	O	O
the	the	O	O	O	O
number	number	O	O	O	O
of	of	O	O	O	O
dark-stained	dark-stained	O	O	O	O
alpha-motoneurons	alpha-motoneurons	O	O	O	O
after	after	O	O	O	O
morphine-induced	morphine-induced	O	O	O	O
spastic	spastic	O	O	OTHERS	I
paraparesis	paraparesis	O	O	OTHERS	I
compared	compared	O	O	O	O
with	with	O	O	O	O
the	the	O	O	O	O
saline	saline	O	O	O	O
group	group	O	O	O	O
.	.	O	O	O	O

These	these	O	O	O	O
data	data	O	O	O	O
indicate	indicate	O	O	O	O
that	that	O	O	O	O
IT	it	O	O	O	O
morphine	morphine	CHEMICALS	O	OTHERS	I
induces	induces	O	O	O	O
spastic	spastic	O	O	OTHERS	I
paraparesis	paraparesis	O	O	OTHERS	I
with	with	O	O	O	O
a	a	O	O	O	O
concomitant	concomitant	O	O	O	O
increase	increase	O	O	O	O
in	in	O	O	O	O
CSF	csf	O	O	O	O
glutamate	glutamate	CHEMICALS	O	OTHERS	I
,	,	O	O	O	O
which	which	O	O	O	O
is	is	O	O	O	O
involved	involved	O	O	O	O
in	in	O	O	O	O
NMDA	nmda	CHEMICALS	O	OTHERS	I
receptor	receptor	O	O	O	O
activation	activation	O	O	O	O
.	.	O	O	O	O

We	we	O	O	O	O
suggest	suggest	O	O	O	O
that	that	O	O	O	O
opioids	opioids	O	O	O	O
may	may	O	O	O	O
be	be	O	O	O	O
neurotoxic	neurotoxic	O	DISEASE	OTHERS	I
in	in	O	O	O	O
the	the	O	O	O	O
setting	setting	O	O	O	O
of	of	O	O	O	O
spinal	spinal	O	DISEASE	OTHERS	I
cord	cord	O	DISEASE	OTHERS	I
ischemia	ischemia	O	DISEASE	OTHERS	I
via	via	O	O	O	O
NMDA	nmda	CHEMICALS	O	OTHERS	I
receptor	receptor	O	O	O	O
activation	activation	O	O	O	O
.	.	O	O	O	O

